Another exploratory clinical study aimed to assess the safety and preliminary efficacy of immunotherapy using PD-1 knockout anti-MUC1 CAR-T cells (AJMUC1) in treating advanced MUC1-positive BC. The gene discussed is MUC1; the disease is breast cancer.